Share:
Share this content in WeChat
X
Experience Exchang
The correlation between the characteristics of middle cerebral artery atherosclerotic plaque, cerebral perfusion and the occurrence of acute cerebral infarction
YAN Tianzhi  ZHANG Chao  LIU Qingxiang  HUANG Qi  HUANG Xianjun  ZHOU Yunfeng 

Cite this article as: Yan TZ, Zhang C, Liu QX, et al. The correlation between the characteristics of middle cerebral artery atherosclerotic plaque, cerebral perfusion and the occurrence of acute cerebral infarction[J]. Chin J Magn Reson Imaging, 2022, 13(5): 106-110. DOI:10.12015/issn.1674-8034.2022.05.019.


[Abstract] Objective To explore the high-risk plaque characteristics and perfusion parameters associated with acute cerebral infarction (ACI) in patients with symptomatic middle cerebral artery (MCA) atherosclerotic stenosis using high-resolution magnetic resonance vessel wall imaging (HRMR-VWI) and CT perfusion imaging (CTP).Materials and Methods The data of HRMR-VWI and CTP in 64 patients with symptomatic MCA atherosclerotic stenosis whose onset time was less than 4 weeks were analyzed retrospectively. According to diffusion weight imaging (DWI) and clinical manifestations, patients were divided into ACI group and transient ischemic attack (TIA) group. The differences of plaque characteristics, perfusion parameters and collateral grade between the two groups were analyzed. Multivariate Logistic regression and receiver operating characteristic (ROC) curve analysis were performed to evaluate the predictive performance and the AUC.Results A total of 64 patients were included.There were 25 patients [age: (55.12±11.20) y; 10 female] in TIA group and 39 patients [age: (57.90±9.62) y; 11 female] in ACI group. There was no significant difference in sex (P=0.327) and age (P=0.296) between the two groups. Compared with TIA group, the plaque length [6.10 (3.20, 12.3) mm vs. 4.10 (2.15, 5.55) mm; P=0.006], the burden [86.83% (80.26%, 100.00%) vs. 78.46% (72.70%, 87.66%); P=0.007], the degree of stenosis [86.76% (76.19%, 100.00%) vs. 75.72% (60.94%, 85.84%), P=0.008], the degree of enhancement (P<0.001) and the enhancement index [(1.19±0.55) vs. (0.58±0.46); P<0.001] were larger. Meanwhile, the values of relative mean transit time (rMTT) [(1.19±0.22) vs. (1.05±0.17); P=0.007], relative time to drain (rTTD) [(1.52±0.47) vs. (1.19±0.30); P=0.003], and relative time to the center of the impulse response function (rTmax) [(2.26±1.33) vs. (1.55±0.67); P=0.007] in ACI group were higher than those in TIA group. Multivariate Logistic regression analysis showed plaque length (OR=1.17, 95% CI: 1.001-1.362, P=0.049), the degree of enhancement (OR=5.18, 95% CI: 1.848-14.522, P=0.002) and rTmax (OR=2.32, 95% CI: 1.019-5.298, P=0.045) were significantly independent predictors of ACI. The prediction efficiency of the combination of plaque length, the degree of enhancement and rTmax was the best (AUC=0.862; 95% CI: 0.767-0.956).Conclusions HRMR-VWI combined with CTP can comprehensively evaluate the characteristics of symptomatic MCA atherosclerotic plaque and downstream perfusion state, which is helpful to identify patients with high-risk MCA atherosclerotic stenosis associated with ACI.
[Keywords] high-resolution magnetic resonance vessel wall imaging;computed tomography perfusion imaging;middle cerebral artery atherosclerotic;transient ischemic attack;acute cerebral infarction;magnetic resonance imaging

YAN Tianzhi1   ZHANG Chao1   LIU Qingxiang1   HUANG Qi1   HUANG Xianjun2   ZHOU Yunfeng1*  

1 Department of Radiology, Yijishan Hospital of Wannan Medical College, Wuhu 241000, China

2 Department of Neurology, Yijishan Hospital of Wannan Medical College, Wuhu 241000, China

Zhou YF, E-mail: zhouyunfeng808@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS "Peak" Backbone Program of Scientific Research Ability of Yijishan Hospital of Wannan Medical College (No. GF2019G13).
Received  2021-12-07
Accepted  2022-03-23
DOI: 10.12015/issn.1674-8034.2022.05.019
Cite this article as: Yan TZ, Zhang C, Liu QX, et al. The correlation between the characteristics of middle cerebral artery atherosclerotic plaque, cerebral perfusion and the occurrence of acute cerebral infarction[J]. Chin J Magn Reson Imaging, 2022, 13(5): 106-110. DOI:10.12015/issn.1674-8034.2022.05.019.

[1]
Wong KS, Caplan LR, Kim JS. Stroke Mechanisms[J]. Front Neurol Neurosci, 2016, 40: 58-71. DOI: 10.1159/000448302.
[2]
Gao S, Wang YJ, Xu AD, et al. Chinese ischemic stroke subclassification[J]. Front Neurol, 2011, 2: 6. DOI: 10.3389/fneur.2011.00006.
[3]
Feng X, Chan KL, Lan L, et al. Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications[J]. Stroke, 2019, 50(10): 2692-2699. DOI: 10.1161/STROKEAHA.119.025732.
[4]
Yu YP, Tan L. The Vulnerability of Vessels Involved in the Role of Embolism and Hypoperfusion in the Mechanisms of Ischemic Cerebrovascular Diseases[J]. Biomed Res Int, 2016, 2016: 8531958. DOI: 10.1155/2016/8531958.
[5]
Liu S, Tang R, Xie W, et al. Plaque characteristics and hemodynamics contribute to neurological impairment in patients with ischemic stroke and transient ischemic attack[J]. Eur Radiol, 2021, 31(4): 2062-2072. DOI: 10.1007/s00330-020-07327-1.
[6]
Zhu J, Wang H, Hu WJ, et al. Value of one-stop dynamic CTA combined with CTP in evaluating the prognosis of patients with unilateral middle cerebralaryery occlusion[J]. Radiol Prac, 2021, 36(9): 1074-1080. DOI: 10.13609/j.cnki.1000-0313.2021.09.001.
[7]
Zhao DL, Li C, Chen XH, et al. Reproducibility of 3.0T High-Resolution Magnetic Resonance Imaging for the Identification and Quantification of Middle Cerebral Arterial Atherosclerotic Plaques[J]. J Stroke Cerebrovasc Dis, 2019, 28(7): 1824-1831. DOI: 10.1016/j.jstrokecerebrovasdis.2019.04.020.
[8]
Lu Y, Ye MF, Zhao JJ, et al. Gadolinium enhancement of atherosclerotic plaque in the intracranial artery[J]. Neurol Res, 2021: 1-10. DOI: 10.1080/01616412.2021.1949682.
[9]
Di Napoli A, Cheng SF, Gregson J, et al. Arterial Spin Labeling MRI in Carotid Stenosis: Arterial Transit Artifacts May Predict Symptoms[J]. Radiology, 2020, 297(3): 652-660. DOI: 10.1148/radiol.2020200225.
[10]
Shi ZQ, Jia L, Jia WX, et al. Study of the relationship between vascular wall changes of vertebrobasilar atherosclerosis and ischemic stroke by HRMR-VWI[J]. Chin J Magn Reson Imaging, 2019, 10(10): 743-747. DOI: 10.12015/issn.1674-8034.2019.10.005.
[11]
Park MS, Kwon S, Lee MJ, et al. Identification of High Risk Carotid Artery Stenosis: A Multimodal Vascular and Perfusion Imaging Study[J]. Front Neurol, 2019, 10: 765. DOI: 10.3389/fneur.2019.00765.
[12]
Zhao Y, Jin C, Wang LT, et al. Distribution and morphological characteristics of symptomatic atherosclerotic plaques in the middle cerebral artery using high-resolution magnetic resonance imaging[J]. Chin J Neurol, 2019, 52(9): 724-731. DOI: 10.3760/cma.j.issn.1006-7876.2019.09.005.
[13]
Liu X, Jiang T, Song H, et al. HRMRI Associated with Ischemic Stroke in Middle Cerebral Artery Atherosclerotic Plaque[J]. Chin J Clin Radiol, 2020, 39(6): 1041-1045. DOI: 10.13437/j.cnki.jcr.2020.06.003.
[14]
d'Esterre CD, Trivedi A, Pordeli P, et al. Regional Comparison of Multiphase Computed Tomographic Angiography and Computed Tomographic Perfusion for Prediction of Tissue Fate in Ischemic Stroke[J]. Stroke, 2017, 48(4): 939-945. DOI: 10.1161/STROKEAHA.116.015969.
[15]
Tan JC, Dillon WP, Liu S, et al. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients[J]. Ann Neurol, 2007, 61: 533-543. DOI: 10.1002/ana.21130.
[16]
Yang WJ, Abrigo J, Soo YO, et al. Regression of Plaque Enhancement Within Symptomatic Middle Cerebral Artery Atherosclerosis: A High-Resolution MRI Study[J]. Front Neurol, 2020, 11: 755. DOI: 10.3389/fneur.2020.00755.
[17]
Buon R, Guidolin B, Jaffre A, et al. Carotid Ultrasound for Assessment of Nonobstructive Carotid Atherosclerosis in Young Adults with Cryptogenic Stroke[J]. J Stroke Cerebrovasc Dis, 2018, 27(5): 1212-1216. DOI: 10.1016/j.jstrokecerebrovasdis.2017.11.043.
[18]
Zhao L, Zhao H, Xu Y, et al. Plaque Length Predicts the Incidence of Microembolic Signals in Acute Anterior Circulation Stroke[J]. Dis Markers, 2021, 2021: 2005369. DOI: 10.1155/2021/2005369.
[19]
Liu S, Luo Y, Wang C, et al. Combination of Plaque Characteristics, Pial Collaterals, and Hypertension Contributes to Misery Perfusion in Patients With Symptomatic Middle Cerebral Artery Stenosis[J]. J Magn Reson Imaging, 2020, 51(1): 195-204. DOI: 10.1002/jmri.26778.
[20]
Kerwin WS, Oikawa M, Yuan C, et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis[J]. Magn Reson Med, 2008, 59(3): 507-514. DOI: 10.1002/mrm.21532.
[21]
Cui B, Yang D, Zheng W, et al. Plaque enhancement in multi-cerebrovascular beds associates with acute cerebral infarction[J]. Acta Radiol, 2021, 62(1): 102-112. DOI: 10.1177/0284185120915604.
[22]
Song JW, Pavlou A, Xiao J, et al. Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis: A Meta-Analysis[J]. Stroke, 2021, 52(1): 193-202. DOI: 10.1161/STROKEAHA.120.031480.
[23]
Kwee RM, Qiao Y, Liu L, et al. Temporal course and implications of intracranial atherosclerotic plaque enhancement on high-resolution vessel wall MRI[J]. Neuroradiology, 2019, 61(6): 651-657. DOI: 10.1007/s00234-019-02190-4.
[24]
Zhang X, Chen L, Li S, et al. Enhancement Characteristics of Middle Cerebral Arterial Atherosclerotic Plaques Over Time and Their Correlation With Stroke Recurrence[J]. Magn Reson Imaging, 2021, 53(3): 953-962. DOI: 10.1002/jmri.27351.
[25]
de Havenon A, Khatri P, Prabhakaran S, et al. Hypoperfusion Distal to Anterior Circulation Intracranial Atherosclerosis is Associated with Recurrent Stroke[J]. Neuroimaging, 2020, 30(4): 468-470. DOI: 10.1111/jon.12710.
[26]
Lu SS, Ge S, Su CQ, et al. MRI of plaque characteristics and relationship with downstream perfusion and cerebral infarction in patients with symptomatic middle cerebral artery stenosis[J]. J Magn Reson Imaging, 2018, 48(1): 66-73. DOI: 10.1002/jmri.25879.

PREV The neuromechanism of life satisfaction: Evidence from MRI studies
NEXT Value of enhanced MRI radiomics in predicting IDH-1 genotype in gliomas
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn